PIPA520685

ZFYVE26 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA520685-Each-of-1 In Stock ₹ 46,591.50

PIPA520685 - Each of 1

₹ 46,591.50

In Stock

Quantity

1

Base Price: ₹ 46,591.50

GST (18%): ₹ 8,386.47

Total Price: ₹ 54,977.97

Antigen

ZFYVE26

Classification

Polyclonal

Conjugate

Unconjugated

Gene

ZFYVE26

Gene Alias

4930465A13; 9330197E15Rik; A630028O16Rik; FYVE domain-containing centrosomal protein; FYVE-CENT; Gm893; Kiaa0321; mKIAA0321; Spastizin; SPG15; Zfyve26; Zinc finger FYVE domain-containing protein 26; zinc finger FYVE-type containing 26; zinc finger, FYVE domain containing 26

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

211978, 23503, 314265

Content And Storage

Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C

Form

Liquid

Applications

Immunohistochemistry, Western Blot

Concentration

1 mg/mL

Formulation

PBS with 0.02% sodium azide

Gene Accession No.

D4A8G9, Q5DU37, Q68DK2

Gene Symbols

ZFYVE26

Immunogen

A 16 amino acid peptide near the carboxy terminus of human SPG15.

Quantity

100 μg

Primary or Secondary

Primary

Target Species

Human, Mouse, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA520723

--

Img

Thermo Scientific

PIPA521085

--

Img

Thermo Scientific

PIPA521095

--

Img

Thermo Scientific

PIPA521083

--

Img

Thermo Scientific

PIPA520810

--

Img

Thermo Scientific

PIPA521082

--

Img

Thermo Scientific

PIPA520767

--

Img

Thermo Scientific

PIPA521089

--

Description

  • A suggested positive control is rat heart tissue lysate
  • PA5-20685 can be used with blocking peptide PEP-0801
  • Hereditary spastic paraplegias (HSPs) are genetically and phenotypically heterogeneous disorders
  • Spastic paraplegia with thinning of the corpus callosum (ARHSP-TCC) is a relatively frequent form of complicated hereditary spastic paraplegia in which mental retardation and muscle stiffness at onset are followed by slowly progressive paraparesis and cognitive deterioration
  • SPG15 is the second gene known to be responsible for ARHSP-TCC in the Italian population
  • Mutations in this gene are associated with autosomal recessive spastic paraplegia-15
  • SPG15 encodes a protein containing a FYVE zinc finger binding domain which is thought to target these proteins to membrane lipids through interaction with phospholipids in the membrane
  • SPG15 mRNA is widely distributed in human tissues, as well as in rat embryos, suggesting a possible role for this protein during embryonic development
  • SPG15 co-localizes partially with endoplasmic reticulum and endosome markers, suggesting a role in intracellular trafficking
  • Multiple isoforms of SPG15 are known to exist.